Jose‐ramón González‐juanatey

Jose‐ramón González‐juanatey's AcademicInfluence.com Rankings

Medical

#2183

World Rank

#2587

Historical Rank

Cardiology

#191

World Rank

#196

Historical Rank

medical Degrees

Jose‐ramón González‐juanatey

Philosophy

#6358

World Rank

#9383

Historical Rank

Logic

#3534

World Rank

#4712

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Jose‐ramón González‐juanatey's Degrees

Doctorate Medicine University of Santiago de Compostela
PhD Cardiology University of Santiago de Compostela

Why Is Jose‐ramón González‐juanatey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jose‐ramón González‐juanatey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. (2016) (7627)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016) (6692)
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. (2016) (5626)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) (3723)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) (1081)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (983)
Markers of Inflammation and Cardiovascular Disease (2009) (434)
Periodontitis and cardiovascular diseases: Consensus report (2020) (428)
Adiponectin is synthesized and secreted by human and murine cardiomyocytes (2005) (341)
ESC / ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management (2014) (249)
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study (2012) (221)
Participation and adherence to cardiac rehabilitation programs. A systematic review. (2016) (211)
The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. (2007) (208)
The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. (2009) (205)
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. (2004) (179)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey (2005) (163)
Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada (2012) (157)
Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. (1991) (156)
Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. (2010) (146)
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial (2017) (136)
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial (2017) (136)
Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. (2008) (115)
Influence of the size of aortic valve prostheses on hemodynamics and change in left ventricular mass: implications for the surgical management of aortic stenosis. (1996) (113)
Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. (2008) (110)
Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability (2018) (109)
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. (2020) (97)
Glycated albumin, a precursor of advanced glycation end‐products, up‐regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy (2010) (90)
Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction (2002) (89)
Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. (2010) (85)
Heart failure in patients with preserved and deteriorated left ventricular ejection fraction (2005) (84)
Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. (2010) (84)
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. (2006) (84)
Doxazosin Induces Apoptosis in Cardiomyocytes Cultured In Vitro by a Mechanism That Is Independent of &agr;1-Adrenergic Blockade (2003) (83)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) (2014) (83)
Empagliflozin Reduces The Levels Of CD36 And Cardiotoxic Lipids While Improving Autophagy In The Hearts Of Zucker Diabetic Fatty Rats. (2019) (81)
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. (2021) (79)
Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. (1998) (78)
Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary event. (2008) (78)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study (2010) (76)
Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain. (2012) (76)
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia. (2017) (74)
Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension (2008) (73)
Influence of diabetes on the survival of patients hospitalized with heart failure: A 12‐year study (2005) (72)
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy (2018) (70)
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial (2020) (70)
Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study. (2016) (68)
Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure. (2017) (67)
"Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?". (2010) (66)
Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) Bleeding Score in a Contemporary Spanish Cohort of Patients With Non–ST-Segment Elevation Acute Myocardial Infarction (2010) (65)
Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome (2012) (64)
Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4. (2013) (64)
Endolysosomal two‐pore channels regulate autophagy in cardiomyocytes (2016) (58)
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease (2020) (58)
Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels (2010) (57)
[Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. (2006) (57)
Coronary artery disease is associated with higher epicardial Retinol‐binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue (2012) (55)
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. (2009) (54)
Current status of NADPH oxidase research in cardiovascular pharmacology (2013) (54)
Periodontitis and Cardiovascular Diseases. Consensus Report (2020) (54)
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. (2009) (54)
Mehran contrast nephropathy risk score: Is it still useful 10 years later? (2016) (53)
Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. (2008) (51)
Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. (2015) (51)
Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. (2008) (51)
The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period. (2005) (50)
[Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study]. (2008) (50)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
Endoplasmic Reticulum Stress Induces Different Molecular Structural Alterations in Human Dilated and Ischemic Cardiomyopathy (2014) (49)
Differential Gene Expression of Cardiac Ion Channels in Human Dilated Cardiomyopathy (2013) (48)
Prognostic Value of QT/RR Slope in Predicting Mortality in Patients with Congestive Heart Failure (2008) (48)
Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. (2010) (47)
Validating Left Atrial Low Voltage Areas During Atrial Fibrillation and Atrial Flutter Using Multielectrode Automated Electroanatomic Mapping. (2018) (47)
Evidence for a role of advanced glycation end products in atrial fibrillation. (2012) (47)
The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization. (2016) (45)
GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism. (2004) (44)
Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure. (2017) (44)
Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase (2012) (43)
Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart (2012) (43)
Pravastatin Counteracts Angiotensin II-Induced Upregulation and Activation of NADPH Oxidase at Plasma Membrane of Human Endothelial Cells (2010) (42)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
Very brief training for laypeople in hands-only cardiopulmonary resuscitation. Effect of real-time feedback. (2016) (42)
Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism (2007) (41)
Usefulness of the QRS-T angle to improve long-term risk stratification of patients with acute myocardial infarction and depressed left ventricular ejection fraction. (2014) (41)
A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin‐SCORE (2015) (41)
GRACE Risk Score Predicts Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome and Normal Renal Function (2013) (40)
Prognostic value of low ankle–brachial index in patients with hypertension and acute coronary syndromes (2009) (39)
Variations in Platelet Proteins Associated With ST-Elevation Myocardial Infarction: Novel Clues on Pathways Underlying Platelet Activation in Acute Coronary Syndromes (2011) (39)
Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome (2013) (38)
Heart Failure Induces Significant Changes in Nuclear Pore Complex of Human Cardiomyocytes (2012) (38)
Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison. (2009) (38)
Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation. (2013) (38)
[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease]. (2011) (38)
Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. (2011) (37)
The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes (2015) (37)
[Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study]. (2011) (37)
Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study. (2006) (36)
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. (2014) (36)
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. (2011) (34)
Índice tobillo-brazo y riesgo vascular (2003) (34)
Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function (2005) (34)
Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction (2014) (33)
Treatment of massive pulmonary thromboembolism with low intrapulmonary dosages of urokinase. Short-term angiographic and hemodynamic evolution. (1992) (33)
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry (2020) (33)
High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment. (2019) (32)
Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation. (2013) (32)
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report (2012) (32)
Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. (2012) (32)
Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension (2010) (32)
Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature. (2017) (32)
RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure (2014) (31)
Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium (2018) (31)
Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. (2009) (31)
Functional Networks of Nucleocytoplasmic Transport-Related Genes Differentiate Ischemic and Dilated Cardiomyopathies. A New Therapeutic Opportunity (2014) (30)
Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm (2018) (30)
Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease. (2011) (29)
New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process (2016) (29)
Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. (2009) (29)
[Galician study of heart failure in primary care (GALICAP Study)]. (2007) (29)
Training Adult Laypeople in Basic Life Support. A Systematic Review. (2020) (29)
Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease. (2014) (28)
Adipokines and Inflammation: Focus on Cardiovascular Diseases (2020) (28)
Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions (2019) (28)
Leukocyte count as a predictor of the severity ischaemic heart disease as evaluated by coronary angiography. (1993) (28)
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study). (2011) (28)
A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly: Design of the EU-CaRE randomised controlled trial (2016) (28)
Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry. (2017) (27)
Key structural and functional differences between early and advanced glycation products. (2015) (27)
Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease. (2012) (27)
Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome. (2011) (27)
Basic life support training into cardiac rehabilitation programs: A chance to give back. A community intervention controlled manikin study. (2018) (27)
Quality Markers in Cardiology. Main Markers to Measure Quality of Results (Outcomes) and Quality Measures Related to Better Results in Clinical Practice (Performance Metrics). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón): A SEC/SECTCV Consensus Position Paper. (2015) (26)
Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis. (2006) (26)
Cardiac rehabilitation of elderly patients in eight rehabilitation units in western Europe: Outcome data from the EU-CaRE multi-centre observational study (2019) (26)
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. (2003) (26)
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review (2020) (26)
Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology (2012) (25)
Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study. (2012) (25)
Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe (2020) (25)
Atrial fibrillation in patients hospitalized for congestive heart failure: the same prognostic influence independently of left ventricular systolic function? (2006) (25)
Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study. (2014) (25)
Ghrelin, the same peptide for different functions: player or bystander? (2005) (25)
Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level (2016) (25)
[Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile]. (2006) (25)
Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure (2013) (25)
BleeMACS: rationale and design of the study (2016) (25)
Impaired Adipogenesis and Insulin Resistance in Epicardial Fat‐Mesenchymal Cells From Patients With Cardiovascular Disease (2014) (25)
Características de los pacientes con cardiopatías en un área sanitaria de la provincia de A Coruña. Estudio Barbanza 2000 (2003) (24)
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. (2017) (24)
High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation. (2011) (24)
T-Wave Oversensing in Patients With Brugada Syndrome: True Bipolar Versus Integrated Bipolar Implantable Cardioverter Defibrillator Leads Multicenter Retrospective Study (2015) (24)
Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. (2010) (23)
Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study. (2013) (23)
20 years of leptin: Role of leptin in cardiomyocyte physiology and physiopathology. (2015) (23)
Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? (2015) (23)
RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy (2014) (22)
Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians. REPAR Study. (2016) (22)
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. (2011) (22)
Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study. (2009) (22)
High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction. (2013) (22)
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy (2015) (22)
Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). (2013) (22)
Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients (2014) (22)
Exercise‐related severe cardiac events (2018) (21)
Cardiac rehabilitation in the elderly patient in eight rehabilitation units in Western Europe: Baseline data from the EU-CaRE multicentre observational study (2019) (21)
High-Sensitivity C-Reactive Protein is a Predictor of In-Hospital Cardiac Events in Acute Myocardial Infarction Independently of GRACE Risk Score (2012) (21)
Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. (2006) (21)
Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. (2010) (21)
Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension (2011) (21)
A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all-cause mortality in acute coronary syndrome patients. (2013) (21)
Omentin treatment of epicardial fat improves its anti‐inflammatory activity and paracrine benefit on smooth muscle cells (2017) (21)
Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels (2010) (21)
Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry. (2017) (20)
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives (2017) (20)
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries. (2019) (20)
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation (2015) (20)
Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer (2020) (20)
Glucose and Inflammatory Cells Decrease Adiponectin in Epicardial Adipose Tissue Cells: Paracrine Consequences on Vascular Endothelium (2016) (20)
ATP synthase subunit alpha and LV mass in ischaemic human hearts (2014) (19)
Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes. (2017) (19)
Influence of Metabolic Syndrome on Development of Cardiac Allograft Vasculopathy in the Transplanted Heart (2012) (19)
Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets (2020) (19)
Nutritional risk index predicts survival in patients undergoing transcatheter aortic valve replacement. (2019) (19)
SERCA2a: A potential non-invasive biomarker of cardiac allograft rejection. (2017) (19)
Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation (2018) (18)
The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study. (2013) (18)
The Micra Leadless Transcatheter Pacemaker. Implantation and Mid-term Follow-up Results in a Single Center. (2017) (18)
Coronary Artery Dominance and Long-term Prognosis in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Angioplasty. (2016) (18)
Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease (2014) (18)
Challenges in Oral Lipid-lowering Therapy: Position Document of the Spanish Society of Cardiology. (2016) (17)
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. (2013) (17)
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. (2012) (17)
Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings. (2017) (17)
Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study. (2017) (17)
Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance (2016) (17)
Heart Mitochondrial Proteome Study Elucidates Changes in Cardiac Energy Metabolism and Antioxidant PRDX3 in Human Dilated Cardiomyopathy (2014) (17)
Influence of sex and pregnancy on survival in patients admitted with heart failure: Data from a prospective multicenter registry (2018) (17)
Renal transplantation in the elderly: does patient age determine the results? (2005) (17)
Dosing of iodinated contrast volume: A new simple algorithm to stratify the risk of contrast‐induced nephropathy in patients with acute coronary syndrome (2013) (17)
Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG). (2014) (17)
Mortality associated with cardiovascular disease in patients with COVID-19☆ (2020) (17)
Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells (2015) (17)
Clinical implications of white coat hypertension. (1996) (17)
The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients (2020) (17)
Association of blood pressure and its evolving changes with the survival of patients with heart failure. (2008) (17)
Influence of heart failure on nucleolar organization and protein expression in human hearts. (2012) (16)
Risk stratification for the development of heart failure after acute coronary syndrome at the time of hospital discharge: Predictive ability of GRACE risk score. (2015) (16)
Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome (2016) (16)
Cardioembolic Stroke: Call for a Multidisciplinary Approach (2009) (16)
Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes. (2017) (16)
Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs: Consensus Document Elaborated by Nominated Experts of Three Scientific Associations (SER-SEC-AEG) (2014) (16)
Comparison Between 3 Bleeding Scoring Systems in Nonvalvular Atrial Fibrillation Patients. What Can the New ORBIT Score Provide? (2016) (16)
The Healthcare of Patients With Acute and Critical Heart Disease. Position of the Spanish Society of Cardiology. (2016) (16)
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry (2018) (16)
Variability of NT-proBNP and Its Relationship with Inflammatory Status in Patients with Stable Essential Hypertension: A 2-Year Follow-Up Study (2012) (16)
Diagnostic accuracy of computer-assisted electrocardiography in the diagnosis of left ventricular hypertrophy in left bundle branch block. (2012) (16)
Patients with cardiac disease: Changes observed through last decade in out-patient clinics. (2013) (15)
[Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999]. (2002) (15)
[Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study]. (2007) (15)
[Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry]. (2020) (15)
Discharge treatment with angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction (2019) (15)
[Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document]. (2015) (15)
Inflammatory effects of in vivo glycated albumin from cardiovascular patients. (2019) (15)
The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy (2019) (15)
Quality markers in cardiology: measures of outcomes and clinical practice—a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery (2015) (15)
Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis (2018) (14)
Leptin does not Induce Hypertrophy, Cell Cycle Alterations, or Production of MCP-1 in Cultured Rat and Mouse Cardiomyocytes (2005) (14)
TRPM7 is down‐regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function (2016) (14)
Glycated human serum albumin induces NF-κB activation and endothelial nitric oxide synthase uncoupling in human umbilical vein endothelial cells. (2015) (14)
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. (2018) (14)
Trends in Risk Factors and Treatments in Patients With Stable Ischemic Heart Disease Seen at Cardiology Clinics Between 2006 and 2014. (2016) (14)
[Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (DIabetes and VAscular disease) study]. (2009) (14)
[Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document]. (2015) (14)
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. (2021) (14)
Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI) (2021) (14)
Sea cucumbers with an anti-inflammatory effect on endothelial cells and subcutaneous but not on epicardial adipose tissue. (2016) (14)
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. (2013) (14)
Estimation of the major cardiovascular events prevention with Inclisiran. (2020) (14)
Omentin protects H9c2 cells against docetaxel cardiotoxicity (2019) (14)
A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population (2019) (14)
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study (2017) (14)
Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registry. (2016) (14)
The New Labcor‐Santiago Pericardial Bioprosthesis (1991) (13)
Pathological ankle–brachial index is equivalent of advanced age in acute coronary syndromes (2011) (13)
Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches (2016) (13)
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries (2019) (13)
Targeting relatives: Impact of a cardiac rehabilitation programme including basic life support training on their skills and attitudes (2019) (13)
Bleeding risk stratification in an era of aggressive management of acute coronary syndromes. (2014) (13)
Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure. (2017) (13)
Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area. (2017) (13)
RNA sequencing analysis identifies new human collagen genes involved in cardiac remodeling. (2015) (13)
[Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists]. (2006) (12)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
Mortality and cardiovascular morbidity within 30 days of discharge following acute coronary syndrome in a contemporary European cohort of patients: How can early risk prediction be improved? The six-month GRACE risk score. (2015) (12)
The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings. (2019) (12)
Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial) (2020) (12)
Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists. (2014) (12)
Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe A Randomized Clinical Trial (12)
A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol (2021) (12)
Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. (1995) (12)
Relative performance of three formulas to assess renal function at predicting in-hospital hemorrhagic complications in an acute coronary syndrome population. What does the new CKD-EPI formula provide? (2014) (12)
FNDC5/Irisin counteracts lipotoxic-induced apoptosis in hypoxic H9c2 cells. (2019) (12)
Anticoagulation prescription in atrial fibrillation (2011) (12)
Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome? (2014) (12)
Initial real-world experience with PCSK-9 inhibitors in current indications for reimbursement in Spain. (2019) (11)
The presence of heart disease worsens prognosis in patients with COVID-19 (2020) (11)
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines. (2014) (11)
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. (2010) (11)
Influence of the preimplantation QRS axis on responses to cardiac resynchronization therapy. (2008) (11)
[Comparison of coronary risk estimates derived using the Framingham and REGICOR equations]. (2005) (11)
Impact of statins in patients with COVID-19 (2021) (11)
Creatinine-or cystatin C-based equations to estimate glomerular filtration rate in acute myocardial infarction: a disparity in estimating renal function and in mortality risk prediction. (2013) (11)
2D‐DIGE‐based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site (2016) (11)
Update in cardiology: vascular risk and cardiac rehabilitation. (2013) (11)
Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome (2019) (10)
Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function (2017) (10)
Two-pore channels (TPCs): Novel voltage-gated ion channels with pleiotropic functions (2017) (10)
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry. (2020) (10)
Hemodynamics of various designs of 19 mm pericardial aortic valve bioprosthesis. (1996) (10)
The influence of the design on the medium to long-term hemodynamic behavior of 19 mm pericardial aortic valve prostheses. (1996) (10)
Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome. (2019) (10)
Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 and KCNJ2 Genes and CACNG8-Linked Left Ventricular Dysfunction (2015) (10)
Natriuretic Peptides: Consensus Call for Use. (2016) (10)
A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill. (2016) (10)
Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction. (2013) (10)
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry (2018) (10)
Doppler echocardiographic comparison of small (19 mm) bileaflet and pericardial heart valve prostheses in aortic position. (1995) (10)
Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients (2017) (10)
Temporal trends between association of evidence-based treatment and outcomes in patients with non-ST-elevation myocardial infarction. (2018) (9)
"Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients". (2016) (9)
[Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)]. (2014) (9)
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry (2021) (9)
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study. (2022) (9)
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area. (2022) (9)
Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials (2020) (9)
Update in cardiology: vascular risk and cardiac rehabilitation. (2015) (9)
Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure. (2014) (9)
Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. (1997) (9)
[Ankle brachial index and cardiovascular risk]. (2003) (9)
ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end‐stage heart failure patients (2017) (9)
Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe. (2016) (9)
Serum potassium dynamics during acute heart failure hospitalization (2020) (9)
Echocardiographic features of the normofunctional Labcor-Santiago pericardial bioprosthesis. (1994) (9)
Differential Effect of β‐Blockers for Heart Rate Control in Coronary Artery Disease (2011) (9)
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models (2022) (9)
Thromboembolism in patients with pericardial valves in the absence of chronic anticoagulation: 12 years' experience. (1991) (9)
Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes (2018) (9)
Updates on epicardial adipose tissue mechanisms on atrial fibrillation (2021) (9)
Acute and long‐term outcomes of simultaneous atrioventricular node ablation and leadless pacemaker implantation (2018) (9)
Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation. (2019) (9)
Endocarditis with pericardial bioprostheses: clinico-pathologic characteristics, immediate and long term prognosis. (1994) (9)
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid‐range and reduced ejection fraction (2020) (8)
Outcomes of Participants With Diabetes in the ISCHEMIA Trials (2021) (8)
[Clinical management in cardiology. Measurement as a means to improvement]. (2020) (8)
Diagnostic value of N-terminal pro-brain natriuretic peptide in pleural effusions of cardiac origin. (2011) (8)
[Hypertensive heart disease: a proposed clinical classification]. (2006) (8)
Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients (2018) (8)
Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication. (2018) (8)
Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients (2021) (8)
Step-down of enalapril treatment for arterial hypertension. (1999) (8)
Value of QT dispersion analysis for noninvasive detection of cardiac allograft rejection. (2002) (8)
Haemodynamic performance of aortic pericardial bioprostheses and bileaflet prostheses at rest and during exercise: implications for the surgical management of patients with small aortic roots (1999) (8)
Impact of New Criteria for Anticoagulant Treatment in Atrial Fibrillation (2011) (8)
Activity of Leucocyte Elastase in Women with Coronary Artery Disease Documented Using Angiography (1995) (8)
Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection (2019) (8)
Permanent junctional reciprocating tachycardia in a patient with an atypically located accessory pathway in the left lateral mitral annulus. (2016) (8)
Has beta-blocker use increased in patients with heart failure in internal medicine settings? Prognostic implications: RICA registry. (2014) (8)
[Computerized interpretation of the electrocardiogram in the diagnosis of left ventricular hypertrophy. The ELECTROPRES project]. (2011) (8)
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition (2017) (8)
Consensus document and recommendations on the use of natriuretic peptides in clinical practice (2016) (8)
[Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension]. (1997) (8)
Laser technique for the fabrication of blood vessels-like models for preclinical studies of pathologies under flow conditions (2017) (8)
Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system. (2019) (7)
Impacto pronóstico de la localización de la enfermedad aterosclerosa previa en pacientes diabéticos. Estudio Barbanza-diabetes (2008) (7)
Short-term metabolic changes achieved by weight loss in hypertensive patients. (2011) (7)
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention (2020) (7)
Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome. (2015) (7)
Cardiac rehabilitation: The missing link to close the chain of survival? (2017) (7)
Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis (2018) (7)
Plasma CD5L and non-invasive diagnosis of acute heart rejection. (2019) (7)
24 h nesfatin-1 treatment promotes apoptosis in cardiomyocytes (2016) (7)
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure (2019) (7)
Sex-related differences in long-term mortality and heart failure in a contemporary cohort of patients with NSTEACS. The cardiochus-HSUJ registry. (2020) (7)
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long‐Term Survival (2021) (7)
Social media in cardiology: Reasons to learn how to use it (2019) (7)
Systemic sclerosis: a rare cause of heart failure? (2015) (7)
[Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian]. (2013) (7)
Blood pressure control in patients with type 2 diabetes and hypertension (2002) (7)
Formación de población adulta lega en soporte vital básico. Una revisión sistemática (2020) (6)
Cost and Potential Savings of Electronic Consultation and Its Relationship with Reduction in Atmospheric Pollution (2021) (6)
Long-term prognosis of women with Brugada syndrome and Electrophysiologic study. (2020) (6)
Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes study. (2010) (6)
[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study]. (2011) (6)
Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature (2018) (6)
Prognostic Value of hs-CRP After Transcatheter Aortic Valve Implantation (2018) (6)
[Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations]. (2009) (6)
Is safe to discontinue anticoagulation after successful ablation of atrial flutter? (2015) (6)
Attitude and efficacy of cardiologists with respect to smoking in patients after acute coronary syndromes. (2012) (6)
Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission (2017) (6)
Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition. (2020) (6)
Universal electronic consultation (e-consultation) program of a cardiology service. Long-term results. (2021) (6)
[Blood pressure control in hypertensive patients with left ventricular hypertrophy. The VIIDA Study]. (2007) (6)
Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study. (2021) (6)
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention (2019) (6)
Percutaneous coronary intervention in a patient with a CoreValve aortic valve prosthesis. (2010) (6)
CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure (2020) (6)
[2003 update of the Guidelines of the Spanish Society of Cardiology on High Blood Pressure]. (2003) (6)
Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level (2016) (6)
Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue. (2019) (6)
Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation. (2019) (6)
Quantitative assessment of left ventricular size and function in cardiac transplant recipients: Side‐by‐side comparison of real time two‐dimensional echocardiography, contrast‐enhanced two‐dimensional echocardiography, three‐dimensional echocardiography, and contrast‐enhanced three‐dimensional echoc (2019) (6)
Prognostic impact of the SYNTAX score II in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of a four-year all-comers registry (2019) (5)
Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat. (2014) (5)
Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. (2012) (5)
Assessment of long-term quality of life after cavotricuspid isthmus ablation for typical atrial flutter (2014) (5)
New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction. (2020) (5)
[Aortic pseudoaneurysm and acute myocardial infarct secondary to thoracic trauma]. (1994) (5)
Fast track triage for COVID-19 based on a population study: The soda score (2020) (5)
Long‐term cardiac reverse remodeling after cardiac resynchronization therapy (2021) (5)
Association Between Renal Function and Cardiovascular Disease in Patients With Left Ventricular Hypertrophy. VIIDA Study (2009) (5)
Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation. (2020) (5)
Prognostic Effect of Body Mass Index in Patients With an Implantable Cardioverter-defibrillator for Primary Prevention of Sudden Death. (2016) (5)
Obesity-Related Genetic Determinants of Heart Failure Prognosis (2019) (5)
[Influence of sex on mortality in hospitalized patients with congestive heart failure and preserved or depressed systolic function]. (2005) (5)
[Albuminuria and cardiovascular risk: basal results of the KORAL-CARDIO study]. (2006) (5)
Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease. (2015) (5)
Impact of Acute Coronary Syndrome Complicated by Ventricular Fibrillation on Long-term Incidence of Sudden Cardiac Death. (2015) (5)
Influence of prosthesis size and left ventricular mass on left ventricular diastolic reserve in patients with aortic valve prostheses. (2001) (5)
Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial (2021) (5)
[Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines]. (2015) (5)
Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (2021) (5)
Impact of new criteria for anticoagulant treatment in atrial fibrillation. (2011) (4)
Long-term Prognosis of Patients With Non-ST-segment Elevation Acute Myocardial Infarction and Coronary Arteries Without Significant Stenosis. (2015) (4)
[Effect of verapamil and nitrendipine on the left ventricular mass and function (systolic and diastolic) in arterial hypertension]. (1994) (4)
One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. (2022) (4)
Aliskiren affects fatty-acid uptake and lipid-related genes in rodent and human cardiomyocytes. (2011) (4)
Ablation of Inappropriate Sinus Tachycardia (2017) (4)
Benefits of delapril in hypertensive patients along the cardiovascular continuum (2013) (4)
TRENDS IN HYPERTENSION PREVALENCE, CONTROL AND GUIDELINES IMPLEMENTATION IN SPAIN THROUGH LAST DECADE. (2011) (4)
Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open‐heart surgery (2020) (4)
Diagnosis of pulmonary veno-occlusive disease: new criteria for biopsy. (1998) (4)
Ischemic Etiology and Prognosis in Men and Women with Acute Heart Failure (2021) (4)
MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study (2012) (4)
[Use of bisoprolol in heart failure. The BISOCOR observational study]. (2003) (4)
Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence. (2021) (4)
Prognostic value of nutrition status in the response of cardiac resynchronization therapy (2018) (4)
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis (2021) (4)
Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells. (2016) (4)
Relevance of Dementia in Atrial Fibrillation Patients within a Specific European Health Care Area (2018) (4)
Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy (2022) (4)
Short-term and long-term validation of the fastest score in patients with ST-elevation myocardial infarction after primary angioplasty. (2018) (4)
PREDICTION OF BLEEDING ADMISSION IN THE FIRST YEAR AFTER ACUTE CORONARY SYNDROME AND PROGNOSTIC IMPACT: THE CARDIOCHUS BLEEDING RISK SCORE (2014) (4)
Acute pulmonary edema in patients with decompensated heart failure. Role of underlying cardiopathy on the prognosis. (2007) (4)
Diabetes Mellitus in Clinical Cardiology in Spain. Survey by the Working Group on the Heart and Diabetes Regarding the Importance of Diabetes Mellitus in Relation With Other Cardiovascular Diseases (2004) (4)
Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry. (2021) (4)
Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry (2020) (4)
Outcome of Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes (2019) (4)
Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension. (1998) (4)
Predictors and outcomes of heart failure after transcatheter aortic valve implantation using a self-expanding prosthesis. (2020) (4)
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile (2022) (4)
Prognostic impact of SYNTAX II score in patients with ST-elevation myocardial infarction undergoing Primary Percutaneous Coronary Intervention: analysis of a 4-year all-comers registry. (2019) (4)
[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study]. (2011) (4)
Maintenance of blood pressure control and left ventricular performance with small doses of enalapril. (1999) (4)
Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study (2020) (4)
Advanced glycation end products: a mysterious shadow beyond the relationship between HbA1c and atrial fibrillation. (2012) (3)
Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts (2016) (3)
Discrepancy between stress electrocardiographic changes and nuclear myocardial perfusion defects in the prognostic assessment of patients with chest pain. (2013) (3)
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition (2020) (3)
Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy (2018) (3)
XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction (2019) (3)
Impact of Advanced Glycation End Products on Endothelial Function and Their Potential Link to Atherosclerosis (2018) (3)
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID‐REAL registry (2022) (3)
Metabolic syndrome and masticatory hypofunction: a cross-sectional study (2021) (3)
From Prevention to Rehabilitation: Toward a Comprehensive Approach to Tackling Cardiac Arrest. (2019) (3)
Doppler echocardiographic evaluation of the Bioflo pericardial bioprosthesis. (1993) (3)
Risk of pacemaker implantation after uneventful successful cavotricuspid isthmus radiofrequency ablation in patients with common atrial flutter. (2016) (3)
Spironolactone in mild chronic heart failure: insights from a propensity-matched analysis of the MUSIC study cohort. (2013) (3)
Cardiorenal benefits of finerenone: protecting kidney and heart (2023) (3)
Importance of recognizing occult renal disease in hypertensive patients. (2009) (3)
Unruptured sinus of Valsalva aneurysm presenting as NSTEMI. (2016) (3)
Endothelial progenitor cells mobilisation after percutaneous coronary intervention: a pilot study (2016) (3)
Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents? (2020) (3)
[Longer-term results of the cardiology e-consult program in patients with heart failure]. (2021) (3)
[Pneumopericardium complicating bronchogenic carcinoma]. (2002) (3)
Edoxaban's contribution to key endothelial cell functions. (2020) (3)
A Multicentre, 12-Week Study of Imidapril and Candesartan Cilexetil in Patients with Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (2007) (3)
Structural and functional inverse cardiac remodeling after cavotricuspid isthmus ablation in patients with typical atrial flutter. (2012) (3)
Remnant cholesterol in patients admitted for acute coronary syndromes. (2022) (3)
Systolic aortic regurgitation. A new prognostic marker in heart failure patients? (2015) (3)
Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality (2020) (3)
[The presence of heart disease worsens prognosis in patients with COVID-19]. (2020) (3)
Excimer Laser Coronary Atherectomy During Percutaneous Coronary Intervention. (2016) (3)
Relaxin has beneficial effects on liver lipidome and metabolic enzymes (2021) (3)
An electronic consultation program impacts on heart failure patients' prognosis: implications for heart failure care (2022) (3)
[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study]. (2006) (3)
[Sublingual enalapril in hypertensive crisis. A preliminary study]. (1989) (3)
Bioelectronics-on-a-chip for cardio myoblast proliferation enhancement using electric field stimulation (2020) (3)
Post-introduction observation of transcatheter aortic valve implantation in Galicia (Spain). (2015) (2)
Cardiovascular prevention (VI). Use of drugs in the primary prevention of arterial hypertension and dyslipidemia. (2008) (2)
A new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome (2013) (2)
Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure (2018) (2)
Left bundle branch block in atrial fibrillation patients without heart failure. (2013) (2)
Control of cardiovascular risk factors in revascularized patients with diabetes: a subanalysis of the ICP-Bypass study. (2015) (2)
Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management: differences between the European and American Guidelines. (2015) (2)
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]. (2011) (2)
Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction. (2020) (2)
Additive value of diabetes and peripheral arterial disease in the risk stratification of patients admitted after an acute coronary syndrome: a subanalysis of the PAMISCA Study (2009) (2)
[Impact of statins in patients with COVID-19]. (2021) (2)
Fulminant myocarditis with myositis after treatment with immune checkpoint inhibitors. (2021) (2)
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial (2020) (2)
Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries (2022) (2)
Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up (2017) (2)
[Myocardial structure and study of arrhythmias during ambulatory electrocardiographic monitoring in mild essential hypertension]. (1996) (2)
Economic evaluation of Restrictive Vs. Liberal Transfusion Strategy Following Acute Myocardial Infarction (REALITY): trial-based cost effectiveness and cost utility analyses. (2022) (2)
[Effects of NSAID on blood pressure among hypertensive patients with a high cardiovascular risk]. (2006) (2)
ESICM LIVES 2016: part one (2016) (2)
Thirty-second sit-to-stand test as an alternative for estimating peak oxygen uptake and 6-min walking distance in women with breast cancer: a cross-sectional study (2022) (2)
Safety and Efficacy of Endothelial Progenitor Cell Capture Stent in ST-Elevation Acute Myocardial Infarction. GENIA Study (2012) (2)
[Changes in lipid profile after regular intake of canned fish. The influence of addition of isoflavones, omega-3 fatty acids and fitosterols]. (2007) (2)
Use of an angioplasty wire in transseptal puncture: A new application of an old technique. (2020) (2)
The question of heart failure in ONTARGET and TRANSCEND: implications for clinical practice (2009) (2)
The impact of inter‐clinician electronic consultation in patients diagnosed with atrial fibrillation in primary care (2022) (2)
Two-Year Follow-up in Atrial Fibrillation Patients Referred for Catheter Ablation of the Atrioventricular Node. (2014) (2)
Innovative Strategies in Heart Failure: Present and Future. (2018) (2)
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study. (2020) (2)
Leadless Pacemaker Implantation in a Transplanted Heart. (2019) (2)
Direct oral anticoagulants vs. vitamin K antagonist after percutaneous coronary interventions in patients with atrial fibrillation: a metanalysis of cardiac ischemic events. (2020) (2)
MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats (2022) (2)
Acute hyperglycemia: is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function? (2011) (2)
Change in atrial fibrillation status, comments to Val-FAAP registry. (2012) (2)
Experimental and clinical evaluation of formalin containing pericardial bioprostheses for replacement of infected valves. (1995) (2)
Letter by Raposeiras-Roubin et al regarding article, "mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis". (2011) (2)
Clinical management in cardiology. Measurement as a means to improvement (2020) (2)
Contrast-induced nephropathy and bleeding: a bidirectional link with prognostic value in acute coronary syndrome. (2014) (2)
[Atrial fibrillation: from detection to treatment. Role of the family physician, cardiologist and other specialists. New models of clinical management]. (2013) (2)
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation (2022) (2)
Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome (2015) (2)
Changes in autonomic response during cardioneuroablation in an elderly patient with carotid sinus syndrome (2022) (1)
[Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines]. (2015) (1)
Abstract 2659: Increased Cystatin C Serum Levels Improve Risk Stratification in Patients with Acute Coronary Syndrome and Normal Glomerular Filtration Rate (2008) (1)
P911Tolerability and safety of sacubitril/valsartan in high-risk subgroups (2018) (1)
[Left ventricular hypertrophy regression in arterial hypertension. The efficacy of the angiotensin II type 1 receptor antagonists]. (2000) (1)
Late Detachment of an Aortic Prosthetic Valve and Reactivation of Takayasu Arteritis. (2017) (1)
[Activity of leukocyte elastase in coronary disease diagnosed by coronarography]. (1994) (1)
Characteristics of statin-treated patients with diabetes mellitus in Europe and canada: results of the Dyslipidemia International study (2009) (1)
Long-term outcome prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter. (2015) (1)
Letter by González-Salvado et al Regarding Article, "Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevención con Dieta Mediterránea) Trial". (2015) (1)
[Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines]. (2015) (1)
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved (2022) (1)
Ghrelin in the Local Regulation of Endocrine Glands (2006) (1)
Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue‐molecules and SGLT2i dapagliflozin (2022) (1)
Prognostic influence of prior ischemic heart disease in in-hospital mortality of acute coronary syndromes. (2013) (1)
Safety and efficacy of endothelial progenitor cell capture stent in ST-elevation acute myocardial infarction. GENIA Study. (2012) (1)
Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (2021) (1)
Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes (2020) (1)
Subject Index Vol. 27, Suppl. 1, 2009 (2009) (1)
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure (2022) (1)
Bilateral transradial aortic valvuloplasty with double balloon angioplasty: our first experience. (2020) (1)
Impella CP-Assisted High-risk Coronary Percutaneous Intervention: First Experience in Spain. (2017) (1)
Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value (2021) (1)
Ischemic heart disease in women. Data from BARIHD study. (2012) (1)
Comparison and Validation of Recommended QT Interval Correction Formulas for Predicting Cardiac Arrhythmias in Patients With Advanced Heart Failure and Cardiac Resynchronization Devices. (2017) (1)
Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: analysis of ten years all comers registry. (2022) (1)
Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol. (2021) (1)
[Aldosterone blockade in heart failure. So much for so little]. (2002) (1)
[Global treatment of cardiovascular risk in the hypertensive patient]. (2007) (1)
Predictive Value of Thromboembolic Risk Scores Before an Atrial Fibrillation Ablation Procedure: Time for a Consensus? (2013) (1)
[Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols]. (1992) (1)
P6265Prevalence of clinical features of familial hypercholesterolemia in patients admitted for an acute coronary syndrome (2018) (1)
Sacubitril-Valsartan, a New Opportunity for Heart Failure with Recovered Ejection Fraction? (2020) (1)
[Renal function in heart failure patients. Prognostic influence and therapeutic implications]. (2009) (1)
The determinant effect of competing events in the analysis of heart failure incidence after myocardial infarction. (2020) (1)
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure (2020) (1)
[Arterial hypertension: where are we and where are we heading to?]. (1994) (1)
Clinical course of COVID-19 in pulmonary arterial hypertension patients (2021) (1)
P1592Novel protective mechanisms of dapagliflozin on epicardial adipose tissue with insulin resistance, inflammatory chemokines production and low differentiation ability (2017) (1)
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis (2022) (1)
Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice (2017) (1)
Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators (2022) (1)
Clinical considerations on the posology of direct oral anticoagulants. (2016) (1)
Adiponectin as Biomarker in Coronary Artery Disease (2016) (1)
[Anemia in heart failure. Future therapeutic target?]. (2007) (1)
Results of intra-aortic balloon counterpulsation in patients with st-elevation myocardial infarction with cardiogenic shock undergoing percutaneous coronary intervention: is there a benefit? (2013) (1)
[Congenital anomalies of the origin of the coronary arteries. The diagnostic and therapeutic aspects]. (1994) (1)
Fluoroscopic integration of the cardiac computed tomography as a guide for transseptal puncture during atrial fibrillation ablation: A feasibility study. (2015) (1)
Effect of diabetes on the clinical characteristics and prognosis of patients with chronic ischemic heart disease. The CIBAR study. (2010) (1)
Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients (2022) (1)
[Diabetes mellitus in cardiology practice in Spain. Survey by the Working Group on Heart and Diabetes regarding the importance of diabetes mellitus in relation with other cardiovascular diseases]. (2004) (1)
BLOOD PRESSURE CONTROL DURING THE EARLY MORNING IN ESSENTIAL HYPERTENSION DURING ANTIHYPERTENSIVE TREATMENT. ACAMPA STUDY: P1.137 (2000) (1)
[Effect of the location of previous atherosclerotic disease on prognosis in diabetic patients. The Barbanza Diabetes Study]. (2008) (1)
Markers of Right Ventricular Dysfunction Predict Maximal Exercise Capacity After Left Ventricular Assist Device Implantation. (2020) (1)
[After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?]. (2003) (1)
A Novel Calsequestrin 2 Deletion Causing Catecholaminergic Polymorphic Ventricular Tachycardia and Sudden Cardiac Death. (2019) (1)
Neuromodulatory Approaches for Atrial Fibrillation Ablation (2021) (1)
P1927A European randomised controlled trial for m-health guided cardiac rehabilitation in the elderly; results of the EU-CaRE RCT study (2019) (1)
[Clinical features and hospital complications of patients with acute coronary syndromes according to smoking habits]. (2012) (1)
A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME) (2021) (1)
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure (2021) (1)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. (2005) (1)
Curso básico de electrocardiografía. Bases teóricas y aplicación diagnóstica (2001) (1)
Reply to G. Betts’s letter referring to “Serum potassium dynamics during acute heart failure hospitalization” (2021) (0)
Consensus Document on Polypill and Secondary Prevention. Does It Include Patients With Stents? Response. (2016) (0)
Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response. (2022) (0)
[Electrocardiographic patterns in hypertensive patients without atherosclerotic coronary disease. Influence of the left ventricular mass]. (1995) (0)
[Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose]. (2000) (0)
Direct anticoagulants in patients with atrial fibrillation. From clinical trials to real-world records (2017) (0)
P4535Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction (2019) (0)
Left ventricle myocardial deformation pattern in severe aortic valve stenosis without cardiac amyloidosis. The AMY-TAVI trial. (2020) (0)
CONTRAST INDUCED NEPHROPATHY AND BLEEDING: A BIDIRECTIONAL LINK WITH PROGNOSTIC VALUE IN ACS (2013) (0)
Late Phrenic Nerve Stimulation in a Super-responder to Cardiac Resynchronization Therapy. The Toll of Success? (2019) (0)
330 Diabetes mellitus worsens the prognosis of the heart failure with preserved systolic function (2004) (0)
[Pocket echography performed by a family physician: yes to democratization, no to revolution]. (2013) (0)
40Different implant locations of transcatheter leadless pacemaker and electrical performance (2018) (0)
Abstract 11730: A New Index to Characterize Asymptomatic Patients with Essential Hypertension, a Wave to Mitral Flow Propagation Velocity Ratio (2011) (0)
P4734Electron microscopy reveals evidence of perinuclear clustering of mitochondria in cardiac biopsy proven allograft rejection (2019) (0)
Combined Venoarterial Extracorporeal Membrane Oxygenation and Impella for Diffuse Coronary Spasm After Surgical Myocardial Revascularization. (2019) (0)
P443Is there any benefit in adding a defibrillator in elderly patients undergoing cardiac resynchronization therapy device implantation (2017) (0)
A summary about relaxin and its reproductive function (2017) (0)
[Update in kidney and cardiovascular diseases. Conclusion]. (2009) (0)
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis (2022) (0)
Inequalities for which we have no explanation, a reproducible phenomenon in different local health districts. (2011) (0)
Reply to the Editor (1992) (0)
D125: Low doses of enalapril maintain the antihypertensive and cardioreparatory achievements of prolonged treatment with higher doses (1997) (0)
[Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents]. (1997) (0)
Gender differences low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real world patients (2021) (0)
Gene expression of the newly discovered adipokine chemerin is modified by inflammatory agents and insulin in cultured cardiomyocytes (2013) (0)
Pronostic Implications of Blood Pressure Variability (2000) (0)
P1501Micra leadless transcatheter pacemaker implantation and one year follow-up results (2017) (0)
Proteins involved in plateled activation by GPVI and ALPHAIIBBETA3 receptors are differentially regulated in acute coronary symdrome: a platelet proteomics study (2011) (0)
Echocardiographic Biatrial Remodelling and Diastolic Function Assessment in Long-Term Follow-Up after Typical Atrial Flutter Ablation (2014) (0)
P2727Progressive decline in hospital mortality of acute coronary syndrome is mainly driven survival improvement in high-risk patients (2017) (0)
Author's response to reviews Title:Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy Authors: (2014) (0)
Abstract 16464: QRS-T Angle: A Challenge to Improve Long-Term Risk Stratification of Patients With Post-Infarction Left Ventricular Dysfunction (2013) (0)
Incidence and prognostic value of infections during an acute coronary syndrome: a single center experience. (2013) (0)
Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease. (2017) (0)
P6539Patient-associated predictors of 15- and 30-day readmission after hospitalization for Acute Heart Failure (2018) (0)
[Different arterial pressure patterns during ambulatory monitoring in hypertensive patients of both sexes are not associated with different cardiovascular impact]. (1996) (0)
1399Accuracy of the PRECISE-DAPT score vs. CRUSADE score for in-hospital and post-discharge bleeding prediction in patients with acute coronary syndrome (2018) (0)
Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Response. (2017) (0)
Immunometabolic role of leptin and adiponectin in atherosclerosis: relationships with cardiovascular complications in rheumatic diseases. (2013) (0)
The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure (2022) (0)
Clinical management indicators for the cardiovascular area. A note for the debate. Response. (2020) (0)
Septal-dissecting hematoma after percutaneous coronary intervention echocardiographic and magnetic resonance imaging diagnosis and follow-up. (2010) (0)
[Obesity and coronary artery disease. Complex or paradox association?]. (2014) (0)
VALIDATION OF THE GLOBAL REGISTRY OF ACUTE CORONARY EVENTS (GRACE) RISK SCORE FOR 6-MONTH POSTDISCHARGE DEATH IN 1183 SPANISH PATIENTS (2010) (0)
Debate: Refractory angina. The Reducer device as a new therapeutic approach. Perspective from the clinic (2021) (0)
Abstract 20565: Risk Stratification of Acute Heart Failure Based on a Multi-Biomarker Analysis at Admission and Hospital Discharge (2017) (0)
Mechanical Chest Compressions and Traumatic Complications in Out-of-hospital Cardiac Arrest. Is There a Price to Pay? (2020) (0)
Self-management of vitamin K antagonists is more cost-effective than dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain. Response. (2013) (0)
278 Cystatina C is a strong predictor of a new onset heart failure in acute coronary syndrome patients (2007) (0)
Impact of the COVID-19 pandemic upon a universal electronic consultation program (e-consultation) between general practitioners and cardiologists (2023) (0)
Coronary Artery Dominance as a Prognostic Factor: In Anterior Myocardial Infarctions as Well? Response. (2016) (0)
Interinstitutional clinical practice guidelines for the treatment of acute myocardial infarction. (2020) (0)
Análisis del impacto de la implantación del plan de gestión de calidad del proceso asistencial de diabetes en un Área Sanitaria de Galicia (2020) (0)
Preoperative evaluation: surgical risk for cardiac events and functional capacity risk indices (2018) (0)
P2513Offer and participation in different European cardiac rehabilitation programs in the elderly after ACS or coronary revascularization. The EU-CaRE study (2019) (0)
137 Hypertensive and ischaemic congestive heart failure: does aetiology affect survival? (2005) (0)
[Do angiotensin II receptor antagonists substitute angiotensin converting enzyme inhibitors in the treatment of high blood pressure?]. (2000) (0)
P6554Utility of accelerometer programmation in leadless pacemaker regardind location. CARDIOCHUS registry (2019) (0)
On the cost-effectiveness of dabigatran. Response. (2013) (0)
[Arterial hypertension and peripheral artery disease. A dangerous relationship]. (2012) (0)
PCV24 THE MAHLER STUDY: DIFFERENCES IN RESOURCE USE FOR THE MANAGEMENT OF CHRONIC HEART FAILURE ACROSS 6 EUROPEAN COUNTRIES (2003) (0)
XPO1 gene therapy restores cardiac function in rats with chronic induced myocardial infarction (2019) (0)
TCT-140 Prognostic value of manual thrombus aspiration in patients undergoing Primary Percutaneous Coronary Intervention (2014) (0)
P6549Conventional single lead ventricular pacemaker against leadless pacemaker system in real-world patients: prospective one center study. CARDIOCHUS Registry (2019) (0)
PCV39 Cost-Effectiveness of Rivaroxaban in the Treatment of Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease in Spain (2020) (0)
High resolution 2-De-Based proteomics analysis of human atrial fibrilation (2009) (0)
Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020. (2022) (0)
TCT-149 Impact of Chronic Total Occlusion in a Non-Infarct-related Artery on clinical outcomes in patients undergoing Primary Percutanous Coronary Intervention: analysis of a 8 year-all-comers prospective registry. (2016) (0)
Gender differences on healthcare accessibility and outcomes of a electronic inter-clinician consultation program at the cardiology department in a Galician Health Area. (2023) (0)
Correction: Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study (2011) (0)
Abstract 8422: Cardiac Protein Abnormalities of Human Left Ventricular Tissue in Ischemic and Dilated Cardiomyopathy (2011) (0)
[Two cases of massive pulmonary embolism associated with estrogen intake. Diagnostic and therapeutic usefulness of pulmonary angiography]. (1990) (0)
P6361Prognostic value of discharge heart rate in acute heart failure patients: more relevant in atrial fibrillation? (2019) (0)
[Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment]. (1988) (0)
Focus on the Patient With Known Cardiac Disease (2017) (0)
The determinant effect of competing events in the analysis of heart failure incidence after myocardial infarction. (2020) (0)
[The midterm inefficacy of 2 different dosages of chlorthalidone (50 and 25 mg/day) in the regression of left ventricular mass in arterial hypertension]. (1995) (0)
Cardiovascular Diseases: A Challenge for the New Era. (2018) (0)
Detection of the Copy Number Variants of Genes in Patients with Familial Cardiac Diseases by Massively Parallel Sequencing (2022) (0)
COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity (2020) (0)
Predicting the risk of systemic septic embolism in patients with infective endocarditis. (2015) (0)
Cardiovascular risk factors during cancer treatment: prevalence, incidence and prognostic relevance (2020) (0)
P162 PREVALENCE OF LOW HDL-C IN STATIN TREATED PATIENTS – THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
P2620PIONEER-HF criteria ready for the prime time? Data from REDINSCOR II registry (2019) (0)
Inequalities for Which We Have No Explanation, a Reproducible Phenomenon in Different Local Health Districts (2011) (0)
[Impact of concomitant use of P2Y12 inhibitors and proton pump inhibitors on ischemia events in patients with acute coronary syndrome in real world]. (2016) (0)
Polygenic risk score as a key factor in cardiovascular clinical prediction models. (2020) (0)
P6412Prognostic impact of atrial fibrillation in patients with chronic stable coronary heart disease (2018) (0)
Endocardial Injury During Ventricular Assistance with an Intracardiac Microaxial Pump (2009) (0)
Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials. (2022) (0)
TCT-138 Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation myocardial infarction: analysis of a 8 year-all-comers registry. (2016) (0)
[Therapeutic measures in massive pulmonary thromboembolism]. (1992) (0)
P658CHA2DS2-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area (2019) (0)
Biomarker discovery by plasma proteomics in familial LMNA dilated cardiomyopathy (2016) (0)
Abstract 12616: Walking Beyond the Grace Model in the Risk Stratification of Patients With Acute Coronary Syndrome: What Does the Arg, Ncdr and the Euroheart Scores Provide? (2011) (0)
Benefits of reducing the cardiovascular risk in patients with abdominal aortic aneurysm. (2022) (0)
[Electrocardiographic changes during stress test in a patient with a type 1 Brugada electrocardiogram pattern: a curiosity with a clinical implication]. (2013) (0)
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers (2022) (0)
[Systemic arterial hypertension studied as a variable parameter in clinical practice]. (1993) (0)
[Immunological alterations and selectin values in hypertensive patients treated according to current criteria]. (2011) (0)
An opportunity to know about resistant hypertension in our area. (2012) (0)
1106-188 Ghrelin is synthesized and secreted by human cardiomyocytes protecting these cells from apoptosis (2004) (0)
P202 PERSISTENT LIPID ABNORMALITIES IN STATIN TREATED PATIENTS IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL SURVEY STUDY (DYSIS-SPAIN) (2010) (0)
P5673The different role of the advanced glycation end products axis in heart failure and in acute coronary syndrome settings (2018) (0)
MS214 ASSOCIATION BETWEEN LOW HDL-C AND FAMILY HISTORY OF PREMATURE CORONARY HEART DISEASE IN SPANISH STATIN-TREATED PATIENTS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
[Cardiovascular disease and hypertensive cardiomyopathy. Beyond heart]. (2006) (0)
P1717Patients eligible for prolonged dual antiplatelet treatment one year after acute coronary syndrome according to the of PRECISE-DAPT score and DAPT score (2018) (0)
Markers of Right Ventricle Dysfunction Predict Exercise Capacity on Left Ventricular Assist Device (LVAD) Patients (2021) (0)
Des-acyl ghrelin regulates glucose and lipid metabolism in HL-1 cardiomyocytes (2006) (0)
[Work status after extracorporeal surgery: importance of the socioeconomic environment]. (1984) (0)
402 Why do heart failure patients with impaired and normal left ventricular ejection fraction die (2006) (0)
P5256Role of pathophysiological cardiac substrate on prognosis of ambulatory patients with chronic heart failure (2017) (0)
TCT CONNECT-173 Prognostic Impact of SYNTAX II Score in Patients With Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction: Analysis of an 10-Year All-Comers Registry (2020) (0)
DIABETIC AND NON-DIABETIC PATIENTS EXPRESS SIMILAR ADIPOSE TISSUE ADIPOKINE LEVELS (2009) (0)
Ventricular function following drug-induced regression of hypertensive left ventricular hypertrophy. (1999) (0)
New data about atrial fibrillation, comment to the OFRECE study. (2014) (0)
Postoperative left ventricular thrombosis and transthoracic echocardiography: is it enough? (2011) (0)
Refining the Predictive Potential of the Early Repolarization Pattern in Myocardial Infarction: An Elusive Endeavour (2019) (0)
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats. (2023) (0)
Letters to the EditorResponse (2010) (0)
Abstract 15704: Exploratory Analysis of the Efficacy of β-blockersin Patients With Post-infarction Systolic Dysfunction Plus Atrial Fibrillation (2015) (0)
Ethanol infusion in the vein of Marshall: A potential bail-out strategy in cardioneuromodulation procedures? (2022) (0)
TCT CONNECT-23 Impact of Gender on Long-Term Prognosis in Acute ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: Analysis of 10-Year All-Comers Registry (2020) (0)
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction (2023) (0)
Preliminary data from hypertensive patients with albumiinuria & heart disease treated with irbesartan during a year. design of koral-cardio study (2004) (0)
PCV80 Characterization of the Clinical Pathway and Treatment Patterns for Post-Myocardial Infarction Patients: A Physician Survey (2020) (0)
Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level (2016) (0)
Acute Myocardial Infarction (TCT-9 to TCT-62)TCT-42 Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infarction (2014) (0)
P138 RESIDUAL RISK IN SPANISH STATIN TREATED PATIENTS WITH LDL-C AT GOAL. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
P137 PREVALENCE OF LOW HDL-C IN STATIN-TREATED PATIENTS WITH CARDIOVASCULAR DISEASE. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
Percutaneous Coronary Intervention and Cardiac Surgery in Cancer Patients (2017) (0)
[Temporal electric stimulation and right ventricular extension in acute postero-inferior myocardial infarction. Influence on clinical characteristics and prognosis]. (1991) (0)
VALIDATION OF THE CRUSADE BLEEDING RISK SCORE IN PATIENTS WITH NON-ST ELEVATION ACUTE MYOCARDIAL INFARCTION IN SPAIN (2010) (0)
[Genesis of the monomorphous sustained ventricular tachycardia]. (2009) (0)
[Left ventricular structure and (systolic and diastolic) function in hypertensive patients without atherosclerotic coronaropathy]. (1996) (0)
P4464Significative role of edoxaban on endotelial cell functions (2019) (0)
P807Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication (2018) (0)
P3878In trancatheter leadless pacemakers, which location is better? One center experience (2018) (0)
[Thromboembolism with the Ionescu-Shiley bovine pericardial bioprosthesis. Long-term results (11 years)]. (1990) (0)
, Carlos Step-Down of Enalapril Treatment for Arterial Hypertension (1999) (0)
Introduction of Innovations in Heart Disease in Spain: InnovaSEC. (2015) (0)
Sensationalist Headlines: Also in the Scientific Press? Response by Abu-Assi et al. (2016) (0)
[Reality and enigmas in left ventricular hypertrophy in arterial hypertension]. (1992) (0)
Characterization of Advanced Glycation end Products by fluorescence and MALDI-TOF/MS in patients with heart failure (2016) (0)
P2522Exercise-related severe cardiac events (2017) (0)
P6198Plasma levels of the proinflammatory adipocytokine chemerin correlate with lean/fat mass index in patients with heart failure (2017) (0)
[Advanced glycation end-products: new markers of renal dysfunction in patients with chronic heart failure]. (2011) (0)
Response to the comment on "Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure". (2013) (0)
On the Cost-effectiveness of Dabigatran (2019) (0)
[Advances made in the past year (2009) in the therapeutic approach to hypertensive heart disease, myocardial ischemia, and atrial fibrillation]. (2010) (0)
Clinical management in cardiology. Extended hospitalization (2022) (0)
Optical coherence tomography images of three different overlapping stents. (2016) (0)
P1223Attributable risk proportion of uncontrolled low-density lipoprotein cholesterol in recurrent acute coronary syndromes (2019) (0)
MS246 LIPID PROFILE OF SPANISH PATIENTS WITH CORONARY HEART DISEASE TREATED WITH STATINS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
[Use of angiotensin-converting enzyme inhibitors in patients with congestive heart failure. Same efficacy? Same costs?]. (1998) (0)
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke (2021) (0)
[Update in kidney and cardiovascular diseases. Introduction]. (2009) (0)
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy (2015) (0)
P940Focal atrial tachycardia arising from the posterior sinus of valsalva (2017) (0)
[Ignoring familiar decision for increasing organ donations?]. (2006) (0)
A clinician-to-clinician universal electronic consultation programme at the cardiology department of a Galician healthcare area improves healthcare accessibility and outcomes in elderly patients (2023) (0)
[Arterial hypertension: a dynamic concept]. (1989) (0)
[Heart failure prevention in arterial hypertension. Do drug or blood pressure levels influence?]. (2004) (0)
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases (2022) (0)
073_16797-J1 Feasibility of Concurrent Leadless-Pacemaker Implantation and Atrioventricular Node Ablation (2017) (0)
Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events (2021) (0)
Metabolic alterations derived from the absence of Two-Pore Channel 1 (TPCN1) at cardiac level (2016) (0)
Markers of Right Ventricular Dysfunction Predict Maximal Exercise Capacity After Left Ventricular Assist Device Implantation. (2021) (0)
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors (2022) (0)
Professional Competence and Teamwork in the Treatment of Patients With Acute and Critical Heart Disease. Response. (2016) (0)
Exercise Echocardiography in Hypertrophic Cardiomyopathy: Is Upright Evaluation Needed After All? (2020) (0)
[Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction]. (2005) (0)
Evaluation of the impact of an integrated care pathway for pulmonary embolism: a quasi-experimental pre-post study (2021) (0)
Prognosis role of clinical practice guidelines compliance in a chronic ischaemic heart disease primary care cohort. The BARIHD study (2013) (0)
Quality markers in cardiology: measures of outcomes and clinical practice —a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery1 (2015) (0)
A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain (2022) (0)
P3302Radial approach reduces hospital mortality in acute coronary syndrome: a propensity score matched study (2017) (0)
Ischemic Heart Disease and Women: More Answers Are Needed. Response (2012) (0)
Abstract 8413: Differences in Myocyte Enhancer Factor-2 and Nuclear Factor of Activated T Cells Pathways According to Human Heart Failure Aetiology (2011) (0)
P2838Ventricular or atrial epicardial fat secretome can be regulated by acetylcholine: new preclinical models on autonomic dysfunction (2018) (0)
MS257 CHARACTERISTICS OF PATIENTS WITH HIGH CLDL PLUS LOW CHDL AND/OR HIGH TG IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN) (2010) (0)
Is final kissing balloon a safe technique for the final treatment of bifurcation lesions (2013) (0)
[Beyond blood pressure reduction in the treatment of arterial hypertension. Clinical implications of the LIFE study]. (2002) (0)
[Are statins indicated in the prevention of cerebral infarct?]. (2000) (0)
Managing NSTEMI in older patients (2021) (0)
Case reportPermanent junctional reciprocating tachycardia in a patient with an atypically located accessory pathway in the left lateral mitral annulusTaquicardia juncional permanente reciprocante numa doente com via acessória de localização atípica no anel mitral lateral esquerdo (2016) (0)
C0289: Identification of a Microvesicle Protein Network Related to Inflammatory Response and Cardiovascular Disease that Plays a Relevant Role in ST-Elevation Myocardial Infarction (2014) (0)
MS10.4 Prognostic Impact of Syntax II Score In Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis of An 8-Year All-Comers Registry (2018) (0)
84 Atrial fibrillation in patients hospitalized for congestive heart failure: a concomitant condition, or a determinant of life expectancy? (2005) (0)
[Angiotensin II type 1 receptor antagonists in cardiac insufficiency]. (2000) (0)
073_16796-J1 Micra Leadless Pacemaker. Implantation and Mid-Term Follow-Up Results (2017) (0)
Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty. (2022) (0)
Study of the role of the new endolysosomal receptors two pore channels (TPCN1 and TPCN2) in human, mouse and rat heart (2013) (0)
Use of an angioplasty wire in transseptal puncture: A new application of an old technique (2020) (0)
Reply to the letter "Radiofrequency ablation and predictors for faster recovery for tachycardia-induced cardiomyopathy in the pediatric population". (2016) (0)
Clinical treatment and prognosis in patients with acute coronary syndrome and anemia. Response. (2015) (0)
Beta-blocker Use After an Acute Coronary Syndrome. Which one, in Whom, and for How Long? Response. (2015) (0)
MANAGEMENT AND OUTCOMES OF PATIENTS WITH DIABETES MELLITUS (DM) AND STABLE ISCHEMIC HEART DISEASE (SIHD): POOLED DATA FROM THE ISCHEMIA AND ISCHEMIA-CKD TRIALS (2021) (0)
Insufficient Lipid Control in Patients With Coronary Artery Disease: An Unresolved Problem. Response. (2016) (0)
P1466Leadless pacemaker mid and long term follow-up in a single center-study (2020) (0)
GW27-e1086 “Real world” implementation of novel oral antiplatelets in ST-elevation acute myocardial infarction acute coronary syndrome undergoing to primary percutaneous coronary intervention: CHUS registry (2016) (0)
[High prevalence of left ventricular hypertrophy in patients with hypertension of long course]. (2007) (0)
Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified? (2021) (0)
Longer-term results of the cardiology e-consult program in patients with heart failure. (2021) (0)
Update to the Consensus Document on Clinical Use of the Polypill: New Dose Containing Atorvastatin 40 mg. (2018) (0)
P3494Dapagliflozin reduced lactate release by epicardial adipose tissue from CAD patients: switch from fatty acids to glucose aerobic oxidation (2019) (0)
P5786A prospective study on the relevance and prognosis of atrial fibrillation patients presenting chronic obstructive pulmonary disease (2018) (0)
Prevalence and Prognosis of Familial Hypercholesterolemia in Acute Coronary Syndromes Patients (2020) (0)
Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease (2017) (0)
Endocardial autonomic denervation in a patient with neurally mediated syncope and severe cardioinhibitory response. (2020) (0)
Clinician-to-clinician electronic consultation in cardiology is also a digital health technology for cardiovascular care (2023) (0)
Role of microbiome in the cardiovascular continuum. Relationship diet-microbiome and cardiovascular risk. (2023) (0)
Genesis of epicardial adipocytes and its association with progenitor markers, muscarinic receptor type 3 and b-blockers intake in patients with cardiovascular disease (2021) (0)
PCV84 - COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION SPANISH PATIENTS (2018) (0)
Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study. (2022) (0)
Usefulness of Three-dimensional Transthoracic Echocardiograhy in the Localization of the Micra Leadless Pacemaker. (2017) (0)
Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH‐AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study (2022) (0)
European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction (2022) (0)
887-6 Treatment with inhibitors of angiotensin-converting enzyme improves the prognosis of congestive heart failure with preserved systolic function (2004) (0)
[Heart and hypertension: joined or separated?]. (2000) (0)
Corrigendum to: A community intervention study on patients' resuscitation and defibrillation quality after embedded training in a cardiac rehabilitation program. (2019) (0)
[Endocarditis with Ionescu-Shiley's bioprosthesis. Long-term results]. (1989) (0)
[Myocardial ischemia secondary to a bilateral coronary fistula with drainage into the pulmonary artery trunk]. (1994) (0)
Letters to the EditorPercutaneous Coronary Intervention in a Patient With a CoreValve® Prosthesis (2010) (0)
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation (2023) (0)
[Is necessary to perform a transthoracic echocardiogram in all the patients with cryptogenic stroke during hospitalization?]. (2013) (0)
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat (2023) (0)
[Arterial hypertension and hypertensive cardiopathy at the turn of the millenium]. (1999) (0)
Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome. (2022) (0)
Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease (2014) (0)
[The clinical implications of left ventricular hypertrophy in arterial hypertension]. (1990) (0)
[Analysis on the impact of the introduction of a quality management plan of the diabetes care process in a Health Area of Galicia (Spain)]. (2020) (0)
P5862Catecholaminergic polymorphic ventricular tachycardia and sudden cardiac death in the context of a novel deletion in the CASQ2 gene affecting the last three exons (2017) (0)
Fulminant myocarditis with myositis after treatment with immune checkpoint inhibitors (2022) (0)
Percutaneous coronary intervention for control of post-operative bleeding in patients with cardiac angiosarcoma. (2013) (0)
A 3D Printed Patient-specific Simulator for Percutaneous Coronary Intervention. (2019) (0)
Revista Portuguesa de Cardiologia Portuguese Journal of Cardiology IMAGE IN CARDIOLOGY Bioresorbable scaffold adjustment in an ostial lesion with the Szabo technique Ajuste de plataforma biorreabsorvível em lesão ostial pela técnica de Szabo (2019) (0)
Bioresorbable scaffold adjustment in an ostial lesion with the Szabo technique. (2016) (0)
Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system (2019) (0)
Aldosterone Antagonists: From Cirrhosis to Heart Failure? (2017) (0)
P3698Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice (2017) (0)
PROTEOMIC ANALYSIS OF CIRCULATING HUMAN PLATELETS REVEALS POTENTIAL BIOMARKERS IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME (2010) (0)

This paper list is powered by the following services:

Jose‐ramón González‐juanatey

Jose‐ramón González‐juanatey's Academic­Influence.com Rankings

Jose‐ramón González‐juanatey's Degrees

Why Is Jose‐ramón González‐juanatey Influential?

Jose‐ramón González‐juanatey's Published Works

Published Works

Jose‐ramón González‐juanatey's AcademicInfluence.com Rankings